Clinical Trial Update: Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers

View source ↗

Summary

A feasibility assessment of the Aquadex FlexFlow ultrafiltration system for treating non-hospitalized heart failure patients in dedicated heart failure centers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aquadex FlexFlow Ultrafiltration System

Snippet

Sponsor: Clalit Health Services | Conditions: Heart Failure | Status: COMPLETED